                                                                                                                                                                 I




                                                                113TH CONGRESS
                                                                   1ST SESSION                           H. R. 315
                                                                  To provide for the placement of certain synthetic drugs on Schedule I under
                                                                                         the Controlled Substances Act.




                                                                              IN THE HOUSE OF REPRESENTATIVES
                                                                                              JANUARY 18, 2013
                                                                Mrs. EMERSON introduced the following bill; which was referred to the Com-
                                                                    mittee on Energy and Commerce, and in addition to the Committee on
                                                                    the Judiciary, for a period to be subsequently determined by the Speaker,
                                                                    in each case for consideration of such provisions as fall within the juris-
                                                                    diction of the committee concerned




                                                                                                          A BILL
                                                                   To provide for the placement of certain synthetic drugs on
                                                                       Schedule I under the Controlled Substances Act.
                                                                  1               Be it enacted by the Senate and House of Representa-
                                                                  2 tives of the United States of America in Congress assembled,
                                                                  3     SECTION 1. SHORT TITLE.
                                                                  4               This Act may be cited as the ‘‘Synthetic Cathinones
                                                                  5 Control Act of 2013’’.
                                                                  6     SEC. 2. ADDITION OF SYNTHETIC DRUGS TO SCHEDULE I
                                                                  7                             OF THE CONTROLLED SUBSTANCES ACT.
pwalker on DSK7TPTVN1PROD with                                    8               (a) IN GENERAL.—Notwithstanding any other provi-
                                                                  9 sion of the Controlled Substances Act (21 U.S.C. 801 et


                                                                                                                           2
                                                                  1 seq.), the Attorney General shall, not later than 60 days
                                                                  2 after the date of the enactment of this Act, issue a final
                                                                  3 order that schedules the following substances on schedule
                                                                  4 I under section 202(c) of that Act (21 U.S.C. 812(c)):
                                                                  5                        (1) 3,4-methylenedioxymethcathinone (methyl-
                                                                  6               one).
                                                                  7                        (2) Naphthylpyrovalerone (naphyrone).
                                                                  8                        (3) 4-fluoromethcathinone (flephedrone).
                                                                  9                        (4) 4-methoxymethcathinone (methedrone; Bk–
                                                                10                PMMA).
                                                                11                         (5) Ethcathinone (N-ethylcathinone).
                                                                12                         (6) 3,4-methylenedioxyethcathinone (ethylone).
                                                                13                         (7) Beta-keto-N-methyl-3,4-benzodioxyolybutan-
                                                                14                amine (butylone).
                                                                15                         (8) N,N-dimethylcathinone (metamfepramone).
                                                                16                         (9)        Alpha-pyrrolidinopropiophenone                             (alpha-
                                                                17                PPP).
                                                                18                         (10)        4-methoxy-alphapyrrolidinopropiophenone
                                                                19                (MOPPP).
                                                                20                         (11) 3,4-methylenedioxyalphapyrrolidinopro-
                                                                21                piophenone (MDPPP).
                                                                22                         (12)        Alpha-pyrrolidinovalerophenone                            (alpha-
                                                                23                PVP).
pwalker on DSK7TPTVN1PROD with                                  24                         (13) 6,7-dihydro-5H-indeno[5,6-d][1,3]dioxol-6-
                                                                25                amine (MDAI).


                                                                             •HR 315 IH

                                                                                                                           3
                                                                  1                        (14) 3-fluoromethcathinone.
                                                                  2                        (15)                  4′-methyl-α-pyrrolidinobutiophenone
                                                                  3               (MPBP).
                                                                  4               (b) CONFORMING AMENDMENT TO REMOVE DEAD-
                                                                  5     WOOD.—Subsection                        (c) of section 202 of the Controlled
                                                                  6 Substances Act (21 U.S.C. 802) is amended to read as
                                                                  7 follows:
                                                                  8               ‘‘(c) CROSS REFERENCE                           TO      SCHEDULES              OF   CON-
                                                                  9     TROLLED             SUBSTANCES.—Schedules I, II, III, IV, and V
                                                                10 shall consist of the drugs and other substances (by what-
                                                                11 ever official name, common or usual name, chemical name,
                                                                12 or brand name designated) that are set forth in the respec-
                                                                13 tive schedules in part 1308 of title 21, Code of Federal
                                                                14 Regulations, as they may be amended from time to time,
                                                                15 or in any successor regulation.’’.
                                                                                                                           Æ
pwalker on DSK7TPTVN1PROD with




                                                                             •HR 315 IH

